DYADIC INTERNATIONAL INC Shareholders' Equity
DYADIC INTERNATIONAL INC (DYAI) had Shareholders' Equity of -$2.39 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent -$2.39M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$407.73K.
- 2025-12-31: Stockholders' Equity Attributable to Parent $1.23M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $2.61M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$2.39M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$407.73K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $1.23M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $2.61M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$529.70K 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $923.61K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $2.47M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $3.41M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $3.17M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $4.52M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $5.88M 10-K · filed 2026-03-25 | |
| 2023-09-30 | $7.65M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $8.99M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $10.80M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $11.09M 10-K · filed 2025-03-26 | |
| 2022-09-30 | $12.61M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $13.56M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $16.39M 10-Q · filed 2023-11-08 | $16.39B 10-Q · filed 2022-05-12 |
| 2021-12-31 | $18.39M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $21.90M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $23.16M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $25.69M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $28.45M 10-K · filed 2023-03-29 | |
| 2020-09-30 | $29.99M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $32.09M 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $34.25M 10-Q · filed 2021-11-10 | |
| 2019-12-31 | $35.86M 10-K · filed 2022-03-29 | |
| 2019-09-30 | $37.24M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $38.62M 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $40.59M 10-Q · filed 2020-11-12 | |
| 2019-01-01 | $42.45M 10-Q · filed 2019-08-13 | |
| 2018-12-31 | $42.45M 10-K · filed 2021-03-30 | |
| 2018-09-30 | $42.91M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $46.30M 10-Q · filed 2019-11-13 | |
| 2018-03-31 | $47.83M 10-Q · filed 2019-11-13 | |
| 2018-01-01 | $49.98M 10-Q · filed 2019-08-13 | |
| 2017-12-31 | $49.98M 10-K · filed 2020-03-30 | |
| 2016-12-31 | $57.69M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |